Literature DB >> 9514807

Malignant melanoma metastatic to the ovary.

B Piura1, I Kedar, S Ariad, M Meirovitz, I Yanai-Inbar.   

Abstract

The diagnosis of malignant melanoma metastatic to the ovary is rarely made in living patients. A case of malignant melanoma metastatic to one ovary, skin of both axillae, and brain occurring 7 years after wide local excision of the primary cutaneous lesion on the patient's back is described. The patient had total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, and selective pelvic retroperitoneal lymphadenectomy, followed by whole brain irradiation and chemoimmunotherapy. This case illustrates the clinical variability and unpredictable biologic behavior of malignant melanoma and it is concluded that malignant melanoma metastatic to the ovary should be suspected in any patient who presents with an adnexal mass and has a history of malignant melanoma.

Entities:  

Mesh:

Year:  1998        PMID: 9514807     DOI: 10.1006/gyno.1997.4919

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

Review 1.  Localized intrapancreatic malignant mesothelioma: a rare entity that may be confused with other pancreatic neoplasms.

Authors:  Rosanny Espinal-Witter; Elliot L Servais; David S Klimstra; Michael D Lieberman; Rhonda K Yantiss
Journal:  Virchows Arch       Date:  2010-02-11       Impact factor: 4.064

2.  Diagnostic challenge for ovarian malignant melanoma in premenopausal women: primary or metastatic?

Authors:  Yassir Sbitti; Zouhour Fadoukhair; Habiba Kadiri; Mohamed Oukabli; Ismail Essaidi; Saoussan Kharmoum; Hind M'rabti; Abderrahmane Albouzidi; Mohammed Ichou; Hassan Errihani
Journal:  World J Surg Oncol       Date:  2011-06-17       Impact factor: 2.754

3.  Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report.

Authors:  Anastasios Boutis; Rosalia Valeri; Ippokratis Korantzis; Dimitrios Valoukas; Ioannis Andronikidis; Charalambos Andreadis
Journal:  World J Surg Oncol       Date:  2008-11-20       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.